The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain

by Sebastiano Mercadante, Marco Maltoni, Domenico Russo, Claudio Adile, Patrizia Ferrera, Romina Rossi, Marta Rosati, Alessandra Casuccio
Published 2021-03-01

A Canadian online survey of oncology nurses’ perspectives on the management of breakthrough pain in cancer (BTPc)

by Margaret I. Fitch, Alison McAndrew, Stephanie Burlein-Hall
Published 2013-01-01

A Canadian online survey of oncology nurses’ perspectives on the defining characteristics and assessment of breakthrough pain in cancer

by Margaret I. Fitch, Alison McAndrew, Stephanie Burlein-Hall
Published 2013-04-01

Multidimensional Statistical Technique for Interpreting the Spontaneous Breakthrough Cancer Pain Phenomenon. A Secondary Analysis from the IOPS-MS Study

by Marco Cascella, Anna Crispo, Gennaro Esposito, Cira Antonietta Forte, Sergio Coluccia, Giuseppe Porciello, Alfonso Amore, Sabrina Bimonte, Sebastiano Mercadante, Augusto Caraceni, Massimo Mammucari, Paolo Marchetti, Rocco Domenico Mediati, Silvia Natoli, Giuseppe Tonini, Arturo Cuomo
Published 2021-08-01

Breakthrough Pain in Patients with Lung Cancer. A Secondary Analysis of IOPS MS Study

by Sebastiano Mercadante, Francesco Masedu, Marco Valenti, Federica Aielli
Published 2020-05-01

Oxycodone/Acetaminophen: The Tailoring Combination Treatment for Specific Clinical Profile of Opioid Well-Responsive Cancer Pain

by De Santis S, Simone MD, Mercadante S, Mediati RD, Vellucci R, Marchetti P, Tonini G, Cuomo A, Caraceni A, Natoli S, Armento G, Blasi L, Mammucari M
Published 2021-02-01

Cancer Pain Management: An Italian Delphi Survey from the Rational Use of Analgesics (RUA) Group

by Varrassi G, De Conno F, Orsi L, Puntillo F, Sotgiu G, Zeppetella J, Zucco F
Published 2020-05-01

Assessment and treatment of breakthrough cancer pain: from theory to clinical practice

by Vellucci R, Mediati RD, Gasperoni S, Mammucari M, Marinangeli F, Romualdi P
Published 2017-09-01

Fentanyl sublingual spray for breakthrough cancer pain in patients receiving transdermal fentanyl

by Alberts, David S, Smith, Christina Cognata, Parikh, Neha, Rauck, Richard L
Published 2016

Real-life management of patients with breakthrough cancer pain caused by bone metastases in Spain

by Ferrer Albiach C, Villegas Estévez F, López Alarcón MD, de Madariaga M, Carregal A, Arranz J, Trinidad Martín-Arroyo JM, Jiménez López AJ, Sanz Yagüe A
Published 2019-07-01

Breakthrough Cancer Pain Is Associated with Spinal Gap Junction Activation via Regulation of Connexin 43 in a Mouse Model

by Xin Li, Siqing Jiang, Hui Yang, Qian Liao, Shousong Cao, Xuebin Yan, Dong Huang
Published 2017-07-01

Characterizing Breakthrough Cancer Pain Using Ecological Momentary Assessment with a Smartphone App: Feasibility and Clinical Findings

by Francisco Villegas, Verónica Martínez-Borba, Carlos Suso-Ribera, Diana Castilla, Irene Zaragoza, Azucena García-Palacios, Carlos Ferrer
Published 2021-06-01

Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pa...

by Jaume Canal-Sotelo, Javier Trujillano-Cabello, Philip Larkin, Núria Arraràs-Torrelles, Ramona González-Rubió, Mariona Rocaspana-Garcia, Eva Barallat-Gimeno
Published 2018-05-01

Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study

by Arturo Cuomo, Marco Cascella, Cira Antonietta Forte, Sabrina Bimonte, Gennaro Esposito, Stefano De Santis, Luigi Cavanna, Flavio Fusco, Mario Dauri, Silvia Natoli, Marco Maltoni, Alessandro Morabito, Rocco Domenico Mediati, Vito Lorusso, Sandro Barni, Giampiero Porzio, Sebastiano Mercadante, Anna Crispo
Published 2020-04-01